Trastuzumab and Chemotherapy May Be Appropriate for Small, Node-Negative, HER2-Positive Breast Cancer

Documenti analoghi

• Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer
  di: Cadoo, Karen A., et al.
  Pubblicazione: (2016)
• Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
  di: Tolaney, Sara M., et al.
  Pubblicazione: (2015)
• Cardiac Outcomes of Patients on Adjuvant Weekly Paclitaxel and Trastuzumab for Node Negative, HER2 Positive Breast Cancer
  di: Dang, Chau, et al.
  Pubblicazione: (2016)
• Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer
  di: Hajjar, Ali, et al.
  Pubblicazione: (2019)
• Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using (89)Zr-Trastuzumab PET/CT
  di: Ulaner, Gary A., et al.
  Pubblicazione: (2016)